Critical Alert
Sunny Pharmtech Inc. Recalls Cyclophosphamide for Injection
This is a Class I recall — the most serious type. There is a reasonable probability of serious health consequences or death.
Source: FDA
CriticalRecall #D-0744-2026Drug / Pharmaceutical
Sunny Pharmtech Inc. Recalls Cyclophosphamide for Injection
Sunny Pharmtech Inc. · Class I — Most Serious
Product Description
Cyclophosphamide for Injection, USP, 2 gram/vial, One Single-Dose Vial, Rx only, Manufactured for: Long Grove Pharmaceuticals, LLC, Rosemont, IL 60018. Manufactured in Taiwan, NDC 81298-8114-1
Reason for Recall
Presence of Particulate Matter; identified as stainless steel
FDA Classification
Class I — Most Serious
A situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Distribution
USA Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
A Class I recall — the FDA's most urgent classification — has been issued for a pharmaceutical product recalled by Sunny Pharmtech Inc. on July 17, 2026. Presence of Particulate Matter; identified as stainless steel. This recall affects 1,464 vials and was distributed in USA Nationwide. Class I recalls indicate a reasonable probability of serious health consequences or death. Consumers should stop using this product immediately.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.